Monopar Therapeutics (MNPR) Q4 2025 Earnings

Nov 13Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1
-0.78
-0.57
-0.35

Details

Expected EPS
-0.386923
Actual EPS
-0.48
Surprise EPS
-0.09
Surprise Percent
-24.06%

Description

⁨Monopar Therapeutics⁩ (⁦MNPR⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts